MeiraGTx Holdings opened lower at $9.13, compared with its previous close of $9.68. In the last trading session, the stock traded between $8.77 and $9.70. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in MeiraGTx Holdings is now worth
$ 44.35
Resulting in a loss of
$ 55.65 (55.65%)
Invest with $1
Note: Past profits do not guarantee future returns.
MeiraGTx Holdings delivered a strong Q2 performance with EPS of $1.71 and sales of $321.434 million. Both figures significantly beat analyst estimates, with sales rising 8.61K% year-over-year and EPS turning profitable from a loss of $(0.48) in the prior year period.
3mo ago
7Aug
MeiraGTx grants equity awards to new employee under Nasdaq rule
MeiraGTx Holdings plc granted 75,000 stock options and 75,000 RSUs to a new employee under Nasdaq Listing Rule 5635(c)(4). The awards feature multi-year vesting schedules tied to continued employment, supporting the company's recruitment for its late-stage genetic medicine pipeline.
3mo ago
8Jul
HC Wainwright reiterates Buy on MeiraGTx, keeps $20 target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates a Buy rating for MeiraGTx Holdings with a maintained $20 price target, signaling continued confidence in the stock's potential.
4mo ago
7Jul
MeiraGTx secures $400 million investment from Oberland Capital
MeiraGTx Holdings plc secured a $400 million investment from Oberland Capital Management LLC, comprising $375 million in non-dilutive royalty financing and $25 million in equity. The funds support the development of therapies for XLRP and RIX, with payments tied to milestones for AAV2-hAQP1 and bota-vec. The agreement includes capped royalties on net sales and provisions for buyback.
